Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  Pharmaceutical Technology Europe E-Alert
 
09 April 2010
IN THIS ISSUE
Sanofi-aventis bio focus
FDA update
A USP welcome
PTE April issue
PTE on LinkedIn
 
Sanofi-Aventis outlines biopharmaceutical investment plans
Sanofi-aventis has outlined an investment plan for adapting its chemical and biotechnology manufacturing facilities in France during the next four years. The goal of the project includes the change of the company’s chemical-industrial activities in France toward biotechnology and vaccine production by 2014. More...
 
Regulatory roundup: FDA approves new formulation for oxycontin to discourage misuse and abuse
The FDA has approved a new formulation for oxycontin that is designed to help discourage misuse and abuse of the drug. Meanwhile, the agency also announced last week that it will begin requiring device manufacturers to provide information in certain premarket applications regarding paediatric patients. More...
 
USP welcomes first visiting scientist of 2010
Last week, the US Pharmacopeial Convention (USP) welcomed Minghao Zhou, of China’s Zhejiang Provincial Institute for Food and Drug Control, to its Rockville, Maryland, headquarters, marking the first scientist to arrive as part of USP’s Visiting Scientist Program. More...
 
Have you seen the April issue of PTE?
This month's issue features articles on spectroscopic tablet analysis, reduced method robustness analytical testing and quality management systems. More...
 
Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...

Product Profile
Elan
Elan Drug Technologies, the world’s leading drug delivery business, develops and manufactures innovative pharmaceuticals using their extensive experience and proprietary drug technologies in partnership with pharmaceutical companies. Read more...

Product Profile
Gen-Probe Life Sciences Ltd
Come and visit us on Stand 49 at BioTrinity 2010, 12-14 April in Newbury, UK, and talk to us about our Clinical/ Pre-Clinical and cGMP Development Services. For further information please contact us on +44 (0) 01506 424 270 or email [email protected].
www.gen-probe.com
Read more...

Event profile
Chemspec 2010
June 9-10, Messe Berlin, Germany

After the success of Chemspec Europe in Barcelona, Berlin is a natural choice as the destination for Chemspec Europe 2010. Germany is at the heart of the European fine and speciality chemicals market and the third largest chemical producer in the world making it an ideal destination for Chemspec Europe to celebrate its 25th anniversary. Read more...

Event profile
Total Processing & Packaging
25-27 May 2010, NEC Birmingham, UK

Featuring Interphex, Total Processing & Packaging is the UK’s flagship exhibition for processing & packaging. With over 500 exhibitors from 30 countries, there are a wealth of pharma manufacturing solutions on display. Read more...

Key Topic Updates
Latest blog posts
Whose gene is it anyway?
Will comparative effectiveness under healthcare reform change drug development?
Healthcare reform passes final legislative hurdle, so what’s next?
More blog posts

April events
Biosimilar Medicines: 8th EGA Annual International Symposium (22–23 April | UK)
Technopharm 2010 (27–29 April | Germany)
LogiPharma 2010 (27–29 April | Switzerland)
More events

Latest peer-reviewed articles
Statistically justifiable visible residue limits
Do visible residue limits make the 10-ppm carryover limit obsolete?
Spherical crystallization for lean solid-dose manufacturing (Part 1)
More peer-reviewed articles

Key Topic Updates

Survey
In light of the fact that most of the world is now out of the recession, how is your company faring compared with this time last year?
  Better 32%
  Worse 34%
  About the same 34%

This week we would like to know...

How do you think the recently passed US healthcare reform law will affect the pharma and biopharma industries?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing [email protected]or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.